T2 Biosystems Inc. (TTOO)
0.12
0.01 (8.99%)
At close: Mar 31, 2025, 9:48 AM
T2 Biosystems Cash Flow Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Net Income | -50.08M | -62M | -49.24M | -46.8M | -59.01M | -51.15M | -62.43M | -54.8M | -45.29M | -31.39M | -20.61M | -14.46M |
| Depreciation & Amortization | 859K | 2.27M | 2.54M | 3.16M | 3.64M | 2.45M | 2.94M | 2.28M | 1.47M | 691K | 584K | 571K |
| Stock-Based Compensation | 4.35M | 6.49M | 7.09M | 3.91M | 5.46M | 9.9M | 4.79M | 4.85M | 4.17M | 1.65M | 578K | 403K |
| Other Working Capital | -4.27M | -959K | -957K | -3.05M | 851K | -1.66M | 140K | 947K | 2.52M | 1.27M | 448K | 256K |
| Other Non-Cash Items | 773K | 3.11M | 3.93M | 3.31M | 2.41M | 2M | 2.6M | 314K | 235K | 117K | 39K | 61K |
| Deferred Income Tax | n/a | n/a | -1.02M | -258K | 280K | 613K | 4.81M | 112K | n/a | 1K | 536K | -51K |
| Change in Working Capital | -4.04M | -503K | -2.17M | -6.54M | 1.86M | -3.94M | -424K | 808K | 1.96M | 744K | 820K | 168K |
| Operating Cash Flow | -48.14M | -50.63M | -38.87M | -43.22M | -45.36M | -40.14M | -47.72M | -46.44M | -37.47M | -28.18M | -18.05M | -13.3M |
| Capital Expenditures | -192K | -339K | -460K | -804K | -761K | -593K | -2.48M | -5.49M | -7.97M | -2.08M | -513K | -283K |
| Acquisitions | n/a | n/a | n/a | 4K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | -50.71M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | 10M | 25.25M | 15.25M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | 10M | 25.25M | -35.46M | n/a | n/a | n/a | n/a | 80K | n/a | 80K | n/a |
| Investing Cash Flow | -192K | 9.66M | 24.79M | -36.26M | -761K | -593K | -2.48M | -5.49M | -7.89M | -2.08M | -433K | -283K |
| Debt Repayment | n/a | n/a | n/a | n/a | -882K | -1.55M | -1.19M | 11.4M | 9.69M | 15.68M | -848K | 4.55M |
| Common Stock Repurchased | n/a | -330K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | -43K | -108K | 567K | 296K | 582K | 1.97M | 1.06M | 40.36M | n/a | n/a | 79.59M | n/a |
| Financial Cash Flow | 52.69M | 29.05M | 20.54M | 85.61M | 6.35M | 49.66M | 18.5M | 51.76M | 45.17M | 73.92M | 38.98M | 4.55M |
| Net Cash Flow | 4.36M | -11.92M | 6.45M | 6.13M | -39.77M | 8.93M | -31.69M | -174K | -187K | 43.65M | 20.49M | -9.04M |
| Free Cash Flow | -48.33M | -50.97M | -39.33M | -44.02M | -46.12M | -40.73M | -50.19M | -51.93M | -45.44M | -30.27M | -18.57M | -13.59M |